Radiotherapy Market by Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron End Users Driven by Prostate and Breast Applications to 2023

Download Free PDF Brochure on Radiotherapy Market Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=57638 .

Report covers radiotherapy market across four major geographies, namely, North America, Europe, Asia-Pacific, & Rest of the World (RoW). North America accounted for largest share of global radiotherapy market in 2016, followed by Europe. Large share of North American region mainly attributed to increasing healthcare expenditure in region, technological advancements, & high adoption of radiotherapy products owing to increasing incidence of cancer.

The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%. Growth in this market is largely driven by factors such as the growing global prevalence of cancer, increasing adoption of radiotherapy in clinical trials, and the increasing number of radiotherapy centers worldwide. However, the underdeveloped public health infrastructure in emerging countries

Competitive Landscape
1 Overview
2 Vendor Inclusion Criteria
3 Competitive Leadership Mapping
4 Visionary Leaders
5 Innovators
6 Dynamic Differentiators
7 Emerging Companies
8 Competitive Benchmarking
9 Analysis of Product Portfolio of Major Players in the Radiotherapy Market (25 Players)
10 Business Strategies Adopted By Major Players in the Radiotherapy Market (25 Players)

More Information on Radiotherapy Market Report Now at
http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=57638 .

Global radiotherapy market report analyzes by type, product type, application, end user, & region. Based on type, external beam radiotherapy segment accounted for largest share in 2016. Growing adoption of this therapy in emerging markets & development of advanced external beam radiotherapy devices to localize tumorous cells while minimizing harm to surrounding healthy cells are some of major factors contributing to growth of this market segment.

In radiotherapy market report electron-emitting high-energy linear accelerators segment expected to account for largest share of external beam radiotherapy market in 2016. Development of advanced linear accelerators and growing adoption of these devices are some of factors driving growth of this market. High growth in this segment can be attributed to growing number of new cancer cases, improvements in healthcare facilities.

Radiotherapy market covers external beam radiotherapy & internal beam radiotherapy applications for various cancers. In 2016, prostate segment held largest share in both segments. Growing incidence of prostate cancer & high success rates achieved with external beam radiation are major factors driving growth of this market segment. This report studies radiotherapy market based on product type, type, application, & end user.

Stakeholders Covered in Radiotherapy Market Report as Follows
• Radiotherapy System and Product Manufacturers, Suppliers, and Software Providers
• Radiotherapy Product Distributors
• Medical Research Laboratories
• Cancer Research Organizations
• Academic Medical Centers and Universities
• Business Research and Consulting Service Providers

Inquire for Discount Now at “Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region - Global Forecasts to 2022” report now at http://www.rnrmarketresearch.com/contacts/discount?rname=57638 .

The major players in the market includeVarian Medical Systems, Inc. (US), Elekta AB (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc (US), P-cure Ltd. (Israel), Theragenics Corporation (US), and C.R.Bard, Inc. (US), among others.
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
• By Designation: C-level (26%), Director-level (30%), and Others (44%)
• By Region: North America (35%), Europe (26%), APAC (23%), and RoW (16%)

This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the radiotherapy market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

RnRMarketResearch is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@rnrmarketresearch.com

This release was published on openPR.